nodes	percent_of_prediction	percent_of_DWPC	metapath
Desmopressin—PTGS2—Lenalidomide—hematologic cancer	0.114	0.209	CbGbCtD
Desmopressin—PTGS2—Thalidomide—hematologic cancer	0.0608	0.111	CbGbCtD
Desmopressin—PTGS1—Bortezomib—hematologic cancer	0.0589	0.108	CbGbCtD
Desmopressin—PTGS1—Thalidomide—hematologic cancer	0.0513	0.0941	CbGbCtD
Desmopressin—PTGS1—Ifosfamide—hematologic cancer	0.0452	0.0828	CbGbCtD
Desmopressin—PTGS1—Imatinib—hematologic cancer	0.0432	0.0791	CbGbCtD
Desmopressin—PTGS2—Triamcinolone—hematologic cancer	0.0421	0.0772	CbGbCtD
Desmopressin—PTGS2—Betamethasone—hematologic cancer	0.0362	0.0662	CbGbCtD
Desmopressin—PTGS2—Cisplatin—hematologic cancer	0.026	0.0477	CbGbCtD
Desmopressin—PTGS2—Etoposide—hematologic cancer	0.0256	0.0469	CbGbCtD
Desmopressin—PTGS1—Etoposide—hematologic cancer	0.0216	0.0396	CbGbCtD
Desmopressin—PTGS2—Dexamethasone—hematologic cancer	0.021	0.0385	CbGbCtD
Desmopressin—PTGS2—ovarian follicle—hematologic cancer	0.0056	0.372	CbGeAlD
Desmopressin—AVPR1A—lung—hematologic cancer	0.00272	0.181	CbGeAlD
Desmopressin—AVPR2—lung—hematologic cancer	0.00225	0.15	CbGeAlD
Desmopressin—PTGS1—hematopoietic system—hematologic cancer	0.000707	0.047	CbGeAlD
Desmopressin—PTGS2—hematopoietic system—hematologic cancer	0.000676	0.0449	CbGeAlD
Desmopressin—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000616	0.209	CbGdCrCtD
Desmopressin—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000616	0.209	CbGdCrCtD
Desmopressin—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000602	0.205	CbGdCrCtD
Desmopressin—PTGS1—blood—hematologic cancer	0.000468	0.0311	CbGeAlD
Desmopressin—PTGS2—blood—hematologic cancer	0.000448	0.0298	CbGeAlD
Desmopressin—PTGS2—bone marrow—hematologic cancer	0.000433	0.0288	CbGeAlD
Desmopressin—PTGS1—lung—hematologic cancer	0.000411	0.0273	CbGeAlD
Desmopressin—PTGS2—lung—hematologic cancer	0.000392	0.0261	CbGeAlD
Desmopressin—PTGS1—testis—hematologic cancer	0.000387	0.0258	CbGeAlD
Desmopressin—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000372	0.126	CbGdCrCtD
Desmopressin—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000372	0.126	CbGdCrCtD
Desmopressin—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000363	0.124	CbGdCrCtD
Desmopressin—PTGS1—lymph node—hematologic cancer	0.000281	0.0187	CbGeAlD
Desmopressin—PTGS2—lymph node—hematologic cancer	0.000268	0.0178	CbGeAlD
Desmopressin—Pruritus—Etoposide—hematologic cancer	4e-05	0.000133	CcSEcCtD
Desmopressin—Shock—Prednisone—hematologic cancer	3.99e-05	0.000132	CcSEcCtD
Desmopressin—Pain—Dexamethasone—hematologic cancer	3.98e-05	0.000132	CcSEcCtD
Desmopressin—Pain—Betamethasone—hematologic cancer	3.98e-05	0.000132	CcSEcCtD
Desmopressin—Visual impairment—Doxorubicin—hematologic cancer	3.98e-05	0.000132	CcSEcCtD
Desmopressin—Nervous system disorder—Prednisone—hematologic cancer	3.98e-05	0.000132	CcSEcCtD
Desmopressin—Tachycardia—Prednisone—hematologic cancer	3.96e-05	0.000131	CcSEcCtD
Desmopressin—Skin disorder—Prednisone—hematologic cancer	3.94e-05	0.000131	CcSEcCtD
Desmopressin—Nausea—Gemcitabine—hematologic cancer	3.94e-05	0.000131	CcSEcCtD
Desmopressin—Vomiting—Cisplatin—hematologic cancer	3.93e-05	0.00013	CcSEcCtD
Desmopressin—Hyperhidrosis—Prednisone—hematologic cancer	3.92e-05	0.00013	CcSEcCtD
Desmopressin—Mental disorder—Epirubicin—hematologic cancer	3.91e-05	0.00013	CcSEcCtD
Desmopressin—Rash—Cisplatin—hematologic cancer	3.89e-05	0.000129	CcSEcCtD
Desmopressin—Dermatitis—Cisplatin—hematologic cancer	3.89e-05	0.000129	CcSEcCtD
Desmopressin—Malnutrition—Epirubicin—hematologic cancer	3.89e-05	0.000129	CcSEcCtD
Desmopressin—Erythema—Epirubicin—hematologic cancer	3.89e-05	0.000129	CcSEcCtD
Desmopressin—Diarrhoea—Etoposide—hematologic cancer	3.87e-05	0.000128	CcSEcCtD
Desmopressin—Anorexia—Prednisone—hematologic cancer	3.87e-05	0.000128	CcSEcCtD
Desmopressin—Eye disorder—Doxorubicin—hematologic cancer	3.86e-05	0.000128	CcSEcCtD
Desmopressin—Ill-defined disorder—Methotrexate—hematologic cancer	3.85e-05	0.000128	CcSEcCtD
Desmopressin—Feeling abnormal—Betamethasone—hematologic cancer	3.84e-05	0.000127	CcSEcCtD
Desmopressin—Feeling abnormal—Dexamethasone—hematologic cancer	3.84e-05	0.000127	CcSEcCtD
Desmopressin—Flushing—Doxorubicin—hematologic cancer	3.83e-05	0.000127	CcSEcCtD
Desmopressin—Cardiac disorder—Doxorubicin—hematologic cancer	3.83e-05	0.000127	CcSEcCtD
Desmopressin—Flatulence—Epirubicin—hematologic cancer	3.83e-05	0.000127	CcSEcCtD
Desmopressin—Tension—Epirubicin—hematologic cancer	3.81e-05	0.000126	CcSEcCtD
Desmopressin—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.81e-05	0.000126	CcSEcCtD
Desmopressin—Gastrointestinal pain—Betamethasone—hematologic cancer	3.81e-05	0.000126	CcSEcCtD
Desmopressin—Hypersensitivity—Triamcinolone—hematologic cancer	3.78e-05	0.000125	CcSEcCtD
Desmopressin—Nervousness—Epirubicin—hematologic cancer	3.77e-05	0.000125	CcSEcCtD
Desmopressin—Angiopathy—Doxorubicin—hematologic cancer	3.75e-05	0.000124	CcSEcCtD
Desmopressin—Malaise—Methotrexate—hematologic cancer	3.74e-05	0.000124	CcSEcCtD
Desmopressin—Dizziness—Etoposide—hematologic cancer	3.74e-05	0.000124	CcSEcCtD
Desmopressin—Muscle spasms—Epirubicin—hematologic cancer	3.74e-05	0.000124	CcSEcCtD
Desmopressin—Immune system disorder—Doxorubicin—hematologic cancer	3.73e-05	0.000124	CcSEcCtD
Desmopressin—Vertigo—Methotrexate—hematologic cancer	3.73e-05	0.000124	CcSEcCtD
Desmopressin—Mediastinal disorder—Doxorubicin—hematologic cancer	3.72e-05	0.000123	CcSEcCtD
Desmopressin—Chills—Doxorubicin—hematologic cancer	3.71e-05	0.000123	CcSEcCtD
Desmopressin—Urticaria—Dexamethasone—hematologic cancer	3.7e-05	0.000123	CcSEcCtD
Desmopressin—Urticaria—Betamethasone—hematologic cancer	3.7e-05	0.000123	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.69e-05	0.000123	CcSEcCtD
Desmopressin—Dizziness—Prednisolone—hematologic cancer	3.69e-05	0.000122	CcSEcCtD
Desmopressin—Asthenia—Triamcinolone—hematologic cancer	3.68e-05	0.000122	CcSEcCtD
Desmopressin—Abdominal pain—Betamethasone—hematologic cancer	3.68e-05	0.000122	CcSEcCtD
Desmopressin—Abdominal pain—Dexamethasone—hematologic cancer	3.68e-05	0.000122	CcSEcCtD
Desmopressin—Body temperature increased—Dexamethasone—hematologic cancer	3.68e-05	0.000122	CcSEcCtD
Desmopressin—Body temperature increased—Betamethasone—hematologic cancer	3.68e-05	0.000122	CcSEcCtD
Desmopressin—Nausea—Cisplatin—hematologic cancer	3.67e-05	0.000122	CcSEcCtD
Desmopressin—Insomnia—Prednisone—hematologic cancer	3.67e-05	0.000122	CcSEcCtD
Desmopressin—Paraesthesia—Prednisone—hematologic cancer	3.64e-05	0.000121	CcSEcCtD
Desmopressin—Pruritus—Triamcinolone—hematologic cancer	3.63e-05	0.00012	CcSEcCtD
Desmopressin—Cough—Methotrexate—hematologic cancer	3.62e-05	0.00012	CcSEcCtD
Desmopressin—Mental disorder—Doxorubicin—hematologic cancer	3.62e-05	0.00012	CcSEcCtD
Desmopressin—Ill-defined disorder—Epirubicin—hematologic cancer	3.61e-05	0.00012	CcSEcCtD
Desmopressin—Convulsion—Methotrexate—hematologic cancer	3.6e-05	0.000119	CcSEcCtD
Desmopressin—Vomiting—Etoposide—hematologic cancer	3.6e-05	0.000119	CcSEcCtD
Desmopressin—Malnutrition—Doxorubicin—hematologic cancer	3.6e-05	0.000119	CcSEcCtD
Desmopressin—Erythema—Doxorubicin—hematologic cancer	3.6e-05	0.000119	CcSEcCtD
Desmopressin—Agitation—Epirubicin—hematologic cancer	3.57e-05	0.000118	CcSEcCtD
Desmopressin—Dyspepsia—Prednisone—hematologic cancer	3.57e-05	0.000118	CcSEcCtD
Desmopressin—Rash—Etoposide—hematologic cancer	3.57e-05	0.000118	CcSEcCtD
Desmopressin—Dermatitis—Etoposide—hematologic cancer	3.56e-05	0.000118	CcSEcCtD
Desmopressin—Headache—Etoposide—hematologic cancer	3.54e-05	0.000118	CcSEcCtD
Desmopressin—Flatulence—Doxorubicin—hematologic cancer	3.54e-05	0.000118	CcSEcCtD
Desmopressin—Myalgia—Methotrexate—hematologic cancer	3.54e-05	0.000117	CcSEcCtD
Desmopressin—Chest pain—Methotrexate—hematologic cancer	3.54e-05	0.000117	CcSEcCtD
Desmopressin—Tension—Doxorubicin—hematologic cancer	3.53e-05	0.000117	CcSEcCtD
Desmopressin—Decreased appetite—Prednisone—hematologic cancer	3.52e-05	0.000117	CcSEcCtD
Desmopressin—Rash—Prednisolone—hematologic cancer	3.52e-05	0.000117	CcSEcCtD
Desmopressin—Dermatitis—Prednisolone—hematologic cancer	3.52e-05	0.000117	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.51e-05	0.000116	CcSEcCtD
Desmopressin—Malaise—Epirubicin—hematologic cancer	3.5e-05	0.000116	CcSEcCtD
Desmopressin—Fatigue—Prednisone—hematologic cancer	3.5e-05	0.000116	CcSEcCtD
Desmopressin—Headache—Prednisolone—hematologic cancer	3.5e-05	0.000116	CcSEcCtD
Desmopressin—Discomfort—Methotrexate—hematologic cancer	3.49e-05	0.000116	CcSEcCtD
Desmopressin—Nervousness—Doxorubicin—hematologic cancer	3.49e-05	0.000116	CcSEcCtD
Desmopressin—Vertigo—Epirubicin—hematologic cancer	3.49e-05	0.000116	CcSEcCtD
Desmopressin—Syncope—Epirubicin—hematologic cancer	3.48e-05	0.000116	CcSEcCtD
Desmopressin—Constipation—Prednisone—hematologic cancer	3.47e-05	0.000115	CcSEcCtD
Desmopressin—Muscle spasms—Doxorubicin—hematologic cancer	3.46e-05	0.000115	CcSEcCtD
Desmopressin—Palpitations—Epirubicin—hematologic cancer	3.43e-05	0.000114	CcSEcCtD
Desmopressin—Confusional state—Methotrexate—hematologic cancer	3.42e-05	0.000113	CcSEcCtD
Desmopressin—Loss of consciousness—Epirubicin—hematologic cancer	3.42e-05	0.000113	CcSEcCtD
Desmopressin—Dizziness—Triamcinolone—hematologic cancer	3.39e-05	0.000113	CcSEcCtD
Desmopressin—Cough—Epirubicin—hematologic cancer	3.39e-05	0.000112	CcSEcCtD
Desmopressin—Anaphylactic shock—Methotrexate—hematologic cancer	3.39e-05	0.000112	CcSEcCtD
Desmopressin—Convulsion—Epirubicin—hematologic cancer	3.37e-05	0.000112	CcSEcCtD
Desmopressin—Infection—Methotrexate—hematologic cancer	3.37e-05	0.000112	CcSEcCtD
Desmopressin—Nausea—Etoposide—hematologic cancer	3.36e-05	0.000111	CcSEcCtD
Desmopressin—Hypertension—Epirubicin—hematologic cancer	3.35e-05	0.000111	CcSEcCtD
Desmopressin—Feeling abnormal—Prednisone—hematologic cancer	3.34e-05	0.000111	CcSEcCtD
Desmopressin—Asthenia—Betamethasone—hematologic cancer	3.34e-05	0.000111	CcSEcCtD
Desmopressin—Asthenia—Dexamethasone—hematologic cancer	3.34e-05	0.000111	CcSEcCtD
Desmopressin—Ill-defined disorder—Doxorubicin—hematologic cancer	3.34e-05	0.000111	CcSEcCtD
Desmopressin—Nervous system disorder—Methotrexate—hematologic cancer	3.32e-05	0.00011	CcSEcCtD
Desmopressin—Gastrointestinal pain—Prednisone—hematologic cancer	3.32e-05	0.00011	CcSEcCtD
Desmopressin—Nausea—Prednisolone—hematologic cancer	3.31e-05	0.00011	CcSEcCtD
Desmopressin—Chest pain—Epirubicin—hematologic cancer	3.31e-05	0.00011	CcSEcCtD
Desmopressin—Myalgia—Epirubicin—hematologic cancer	3.31e-05	0.00011	CcSEcCtD
Desmopressin—Agitation—Doxorubicin—hematologic cancer	3.3e-05	0.00011	CcSEcCtD
Desmopressin—Anxiety—Epirubicin—hematologic cancer	3.3e-05	0.000109	CcSEcCtD
Desmopressin—Pruritus—Dexamethasone—hematologic cancer	3.29e-05	0.000109	CcSEcCtD
Desmopressin—Pruritus—Betamethasone—hematologic cancer	3.29e-05	0.000109	CcSEcCtD
Desmopressin—Skin disorder—Methotrexate—hematologic cancer	3.29e-05	0.000109	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.29e-05	0.000109	CcSEcCtD
Desmopressin—Hyperhidrosis—Methotrexate—hematologic cancer	3.28e-05	0.000109	CcSEcCtD
Desmopressin—Discomfort—Epirubicin—hematologic cancer	3.27e-05	0.000108	CcSEcCtD
Desmopressin—Vomiting—Triamcinolone—hematologic cancer	3.26e-05	0.000108	CcSEcCtD
Desmopressin—Malaise—Doxorubicin—hematologic cancer	3.24e-05	0.000108	CcSEcCtD
Desmopressin—Rash—Triamcinolone—hematologic cancer	3.24e-05	0.000107	CcSEcCtD
Desmopressin—Dermatitis—Triamcinolone—hematologic cancer	3.23e-05	0.000107	CcSEcCtD
Desmopressin—Vertigo—Doxorubicin—hematologic cancer	3.23e-05	0.000107	CcSEcCtD
Desmopressin—Anorexia—Methotrexate—hematologic cancer	3.23e-05	0.000107	CcSEcCtD
Desmopressin—Syncope—Doxorubicin—hematologic cancer	3.22e-05	0.000107	CcSEcCtD
Desmopressin—Urticaria—Prednisone—hematologic cancer	3.22e-05	0.000107	CcSEcCtD
Desmopressin—Headache—Triamcinolone—hematologic cancer	3.21e-05	0.000107	CcSEcCtD
Desmopressin—Abdominal pain—Prednisone—hematologic cancer	3.21e-05	0.000106	CcSEcCtD
Desmopressin—Body temperature increased—Prednisone—hematologic cancer	3.21e-05	0.000106	CcSEcCtD
Desmopressin—Confusional state—Epirubicin—hematologic cancer	3.2e-05	0.000106	CcSEcCtD
Desmopressin—Diarrhoea—Betamethasone—hematologic cancer	3.19e-05	0.000106	CcSEcCtD
Desmopressin—Diarrhoea—Dexamethasone—hematologic cancer	3.19e-05	0.000106	CcSEcCtD
Desmopressin—Palpitations—Doxorubicin—hematologic cancer	3.18e-05	0.000105	CcSEcCtD
Desmopressin—Anaphylactic shock—Epirubicin—hematologic cancer	3.17e-05	0.000105	CcSEcCtD
Desmopressin—Oedema—Epirubicin—hematologic cancer	3.17e-05	0.000105	CcSEcCtD
Desmopressin—Loss of consciousness—Doxorubicin—hematologic cancer	3.16e-05	0.000105	CcSEcCtD
Desmopressin—Infection—Epirubicin—hematologic cancer	3.15e-05	0.000105	CcSEcCtD
Desmopressin—Cough—Doxorubicin—hematologic cancer	3.14e-05	0.000104	CcSEcCtD
Desmopressin—Shock—Epirubicin—hematologic cancer	3.12e-05	0.000104	CcSEcCtD
Desmopressin—Convulsion—Doxorubicin—hematologic cancer	3.12e-05	0.000103	CcSEcCtD
Desmopressin—Nervous system disorder—Epirubicin—hematologic cancer	3.11e-05	0.000103	CcSEcCtD
Desmopressin—Hypertension—Doxorubicin—hematologic cancer	3.1e-05	0.000103	CcSEcCtD
Desmopressin—Tachycardia—Epirubicin—hematologic cancer	3.1e-05	0.000103	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.09e-05	0.000102	CcSEcCtD
Desmopressin—Skin disorder—Epirubicin—hematologic cancer	3.08e-05	0.000102	CcSEcCtD
Desmopressin—Dizziness—Dexamethasone—hematologic cancer	3.08e-05	0.000102	CcSEcCtD
Desmopressin—Dizziness—Betamethasone—hematologic cancer	3.08e-05	0.000102	CcSEcCtD
Desmopressin—Hyperhidrosis—Epirubicin—hematologic cancer	3.07e-05	0.000102	CcSEcCtD
Desmopressin—Insomnia—Methotrexate—hematologic cancer	3.07e-05	0.000102	CcSEcCtD
Desmopressin—Myalgia—Doxorubicin—hematologic cancer	3.06e-05	0.000102	CcSEcCtD
Desmopressin—Chest pain—Doxorubicin—hematologic cancer	3.06e-05	0.000102	CcSEcCtD
Desmopressin—Anxiety—Doxorubicin—hematologic cancer	3.05e-05	0.000101	CcSEcCtD
Desmopressin—Nausea—Triamcinolone—hematologic cancer	3.05e-05	0.000101	CcSEcCtD
Desmopressin—Paraesthesia—Methotrexate—hematologic cancer	3.04e-05	0.000101	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.04e-05	0.000101	CcSEcCtD
Desmopressin—Discomfort—Doxorubicin—hematologic cancer	3.02e-05	0.0001	CcSEcCtD
Desmopressin—Anorexia—Epirubicin—hematologic cancer	3.02e-05	0.0001	CcSEcCtD
Desmopressin—Dyspnoea—Methotrexate—hematologic cancer	3.02e-05	0.0001	CcSEcCtD
Desmopressin—Somnolence—Methotrexate—hematologic cancer	3.01e-05	9.99e-05	CcSEcCtD
Desmopressin—Hypersensitivity—Prednisone—hematologic cancer	2.99e-05	9.91e-05	CcSEcCtD
Desmopressin—Dyspepsia—Methotrexate—hematologic cancer	2.98e-05	9.9e-05	CcSEcCtD
Desmopressin—Vomiting—Betamethasone—hematologic cancer	2.96e-05	9.82e-05	CcSEcCtD
Desmopressin—Vomiting—Dexamethasone—hematologic cancer	2.96e-05	9.82e-05	CcSEcCtD
Desmopressin—Confusional state—Doxorubicin—hematologic cancer	2.96e-05	9.82e-05	CcSEcCtD
Desmopressin—Decreased appetite—Methotrexate—hematologic cancer	2.95e-05	9.77e-05	CcSEcCtD
Desmopressin—Rash—Betamethasone—hematologic cancer	2.94e-05	9.74e-05	CcSEcCtD
Desmopressin—Rash—Dexamethasone—hematologic cancer	2.94e-05	9.74e-05	CcSEcCtD
Desmopressin—Oedema—Doxorubicin—hematologic cancer	2.93e-05	9.73e-05	CcSEcCtD
Desmopressin—Anaphylactic shock—Doxorubicin—hematologic cancer	2.93e-05	9.73e-05	CcSEcCtD
Desmopressin—Dermatitis—Betamethasone—hematologic cancer	2.93e-05	9.73e-05	CcSEcCtD
Desmopressin—Dermatitis—Dexamethasone—hematologic cancer	2.93e-05	9.73e-05	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.93e-05	9.71e-05	CcSEcCtD
Desmopressin—Fatigue—Methotrexate—hematologic cancer	2.92e-05	9.69e-05	CcSEcCtD
Desmopressin—Headache—Dexamethasone—hematologic cancer	2.92e-05	9.68e-05	CcSEcCtD
Desmopressin—Headache—Betamethasone—hematologic cancer	2.92e-05	9.68e-05	CcSEcCtD
Desmopressin—Infection—Doxorubicin—hematologic cancer	2.92e-05	9.67e-05	CcSEcCtD
Desmopressin—Asthenia—Prednisone—hematologic cancer	2.91e-05	9.65e-05	CcSEcCtD
Desmopressin—Pain—Methotrexate—hematologic cancer	2.9e-05	9.61e-05	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.89e-05	9.59e-05	CcSEcCtD
Desmopressin—Shock—Doxorubicin—hematologic cancer	2.89e-05	9.58e-05	CcSEcCtD
Desmopressin—Nervous system disorder—Doxorubicin—hematologic cancer	2.88e-05	9.55e-05	CcSEcCtD
Desmopressin—Pruritus—Prednisone—hematologic cancer	2.87e-05	9.52e-05	CcSEcCtD
Desmopressin—Insomnia—Epirubicin—hematologic cancer	2.87e-05	9.52e-05	CcSEcCtD
Desmopressin—Tachycardia—Doxorubicin—hematologic cancer	2.86e-05	9.5e-05	CcSEcCtD
Desmopressin—Skin disorder—Doxorubicin—hematologic cancer	2.85e-05	9.46e-05	CcSEcCtD
Desmopressin—Paraesthesia—Epirubicin—hematologic cancer	2.85e-05	9.45e-05	CcSEcCtD
Desmopressin—Hyperhidrosis—Doxorubicin—hematologic cancer	2.84e-05	9.41e-05	CcSEcCtD
Desmopressin—Dyspnoea—Epirubicin—hematologic cancer	2.83e-05	9.38e-05	CcSEcCtD
Desmopressin—Somnolence—Epirubicin—hematologic cancer	2.82e-05	9.35e-05	CcSEcCtD
Desmopressin—Anorexia—Doxorubicin—hematologic cancer	2.8e-05	9.28e-05	CcSEcCtD
Desmopressin—Feeling abnormal—Methotrexate—hematologic cancer	2.79e-05	9.26e-05	CcSEcCtD
Desmopressin—Dyspepsia—Epirubicin—hematologic cancer	2.79e-05	9.26e-05	CcSEcCtD
Desmopressin—Diarrhoea—Prednisone—hematologic cancer	2.77e-05	9.2e-05	CcSEcCtD
Desmopressin—Gastrointestinal pain—Methotrexate—hematologic cancer	2.77e-05	9.19e-05	CcSEcCtD
Desmopressin—Nausea—Betamethasone—hematologic cancer	2.77e-05	9.17e-05	CcSEcCtD
Desmopressin—Nausea—Dexamethasone—hematologic cancer	2.77e-05	9.17e-05	CcSEcCtD
Desmopressin—Decreased appetite—Epirubicin—hematologic cancer	2.76e-05	9.15e-05	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.74e-05	9.08e-05	CcSEcCtD
Desmopressin—Fatigue—Epirubicin—hematologic cancer	2.73e-05	9.07e-05	CcSEcCtD
Desmopressin—Constipation—Epirubicin—hematologic cancer	2.71e-05	9e-05	CcSEcCtD
Desmopressin—Pain—Epirubicin—hematologic cancer	2.71e-05	9e-05	CcSEcCtD
Desmopressin—Urticaria—Methotrexate—hematologic cancer	2.69e-05	8.93e-05	CcSEcCtD
Desmopressin—Dizziness—Prednisone—hematologic cancer	2.68e-05	8.9e-05	CcSEcCtD
Desmopressin—Abdominal pain—Methotrexate—hematologic cancer	2.68e-05	8.89e-05	CcSEcCtD
Desmopressin—Body temperature increased—Methotrexate—hematologic cancer	2.68e-05	8.89e-05	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.67e-05	8.87e-05	CcSEcCtD
Desmopressin—Insomnia—Doxorubicin—hematologic cancer	2.65e-05	8.8e-05	CcSEcCtD
Desmopressin—Paraesthesia—Doxorubicin—hematologic cancer	2.63e-05	8.74e-05	CcSEcCtD
Desmopressin—Dyspnoea—Doxorubicin—hematologic cancer	2.62e-05	8.68e-05	CcSEcCtD
Desmopressin—Feeling abnormal—Epirubicin—hematologic cancer	2.61e-05	8.67e-05	CcSEcCtD
Desmopressin—Somnolence—Doxorubicin—hematologic cancer	2.61e-05	8.65e-05	CcSEcCtD
Desmopressin—Gastrointestinal pain—Epirubicin—hematologic cancer	2.59e-05	8.6e-05	CcSEcCtD
Desmopressin—Dyspepsia—Doxorubicin—hematologic cancer	2.58e-05	8.57e-05	CcSEcCtD
Desmopressin—Vomiting—Prednisone—hematologic cancer	2.58e-05	8.55e-05	CcSEcCtD
Desmopressin—Rash—Prednisone—hematologic cancer	2.56e-05	8.48e-05	CcSEcCtD
Desmopressin—Dermatitis—Prednisone—hematologic cancer	2.55e-05	8.47e-05	CcSEcCtD
Desmopressin—Decreased appetite—Doxorubicin—hematologic cancer	2.55e-05	8.46e-05	CcSEcCtD
Desmopressin—Headache—Prednisone—hematologic cancer	2.54e-05	8.43e-05	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.53e-05	8.4e-05	CcSEcCtD
Desmopressin—Fatigue—Doxorubicin—hematologic cancer	2.53e-05	8.39e-05	CcSEcCtD
Desmopressin—Urticaria—Epirubicin—hematologic cancer	2.52e-05	8.36e-05	CcSEcCtD
Desmopressin—Pain—Doxorubicin—hematologic cancer	2.51e-05	8.32e-05	CcSEcCtD
Desmopressin—Constipation—Doxorubicin—hematologic cancer	2.51e-05	8.32e-05	CcSEcCtD
Desmopressin—Abdominal pain—Epirubicin—hematologic cancer	2.51e-05	8.32e-05	CcSEcCtD
Desmopressin—Body temperature increased—Epirubicin—hematologic cancer	2.51e-05	8.32e-05	CcSEcCtD
Desmopressin—Hypersensitivity—Methotrexate—hematologic cancer	2.5e-05	8.28e-05	CcSEcCtD
Desmopressin—Asthenia—Methotrexate—hematologic cancer	2.43e-05	8.07e-05	CcSEcCtD
Desmopressin—Feeling abnormal—Doxorubicin—hematologic cancer	2.42e-05	8.02e-05	CcSEcCtD
Desmopressin—Nausea—Prednisone—hematologic cancer	2.41e-05	7.99e-05	CcSEcCtD
Desmopressin—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.4e-05	7.96e-05	CcSEcCtD
Desmopressin—Pruritus—Methotrexate—hematologic cancer	2.4e-05	7.95e-05	CcSEcCtD
Desmopressin—Hypersensitivity—Epirubicin—hematologic cancer	2.34e-05	7.75e-05	CcSEcCtD
Desmopressin—Urticaria—Doxorubicin—hematologic cancer	2.33e-05	7.73e-05	CcSEcCtD
Desmopressin—Abdominal pain—Doxorubicin—hematologic cancer	2.32e-05	7.7e-05	CcSEcCtD
Desmopressin—Body temperature increased—Doxorubicin—hematologic cancer	2.32e-05	7.7e-05	CcSEcCtD
Desmopressin—Diarrhoea—Methotrexate—hematologic cancer	2.32e-05	7.69e-05	CcSEcCtD
Desmopressin—Asthenia—Epirubicin—hematologic cancer	2.28e-05	7.55e-05	CcSEcCtD
Desmopressin—Pruritus—Epirubicin—hematologic cancer	2.24e-05	7.44e-05	CcSEcCtD
Desmopressin—Dizziness—Methotrexate—hematologic cancer	2.24e-05	7.43e-05	CcSEcCtD
Desmopressin—Diarrhoea—Epirubicin—hematologic cancer	2.17e-05	7.2e-05	CcSEcCtD
Desmopressin—Hypersensitivity—Doxorubicin—hematologic cancer	2.16e-05	7.17e-05	CcSEcCtD
Desmopressin—Vomiting—Methotrexate—hematologic cancer	2.15e-05	7.15e-05	CcSEcCtD
Desmopressin—Rash—Methotrexate—hematologic cancer	2.14e-05	7.09e-05	CcSEcCtD
Desmopressin—Dermatitis—Methotrexate—hematologic cancer	2.13e-05	7.08e-05	CcSEcCtD
Desmopressin—Headache—Methotrexate—hematologic cancer	2.12e-05	7.04e-05	CcSEcCtD
Desmopressin—Asthenia—Doxorubicin—hematologic cancer	2.11e-05	6.98e-05	CcSEcCtD
Desmopressin—Dizziness—Epirubicin—hematologic cancer	2.1e-05	6.96e-05	CcSEcCtD
Desmopressin—Pruritus—Doxorubicin—hematologic cancer	2.08e-05	6.89e-05	CcSEcCtD
Desmopressin—Vomiting—Epirubicin—hematologic cancer	2.02e-05	6.69e-05	CcSEcCtD
Desmopressin—Nausea—Methotrexate—hematologic cancer	2.01e-05	6.68e-05	CcSEcCtD
Desmopressin—Diarrhoea—Doxorubicin—hematologic cancer	2.01e-05	6.66e-05	CcSEcCtD
Desmopressin—Rash—Epirubicin—hematologic cancer	2e-05	6.63e-05	CcSEcCtD
Desmopressin—Dermatitis—Epirubicin—hematologic cancer	2e-05	6.63e-05	CcSEcCtD
Desmopressin—Headache—Epirubicin—hematologic cancer	1.99e-05	6.59e-05	CcSEcCtD
Desmopressin—Dizziness—Doxorubicin—hematologic cancer	1.94e-05	6.44e-05	CcSEcCtD
Desmopressin—Nausea—Epirubicin—hematologic cancer	1.88e-05	6.25e-05	CcSEcCtD
Desmopressin—Vomiting—Doxorubicin—hematologic cancer	1.87e-05	6.19e-05	CcSEcCtD
Desmopressin—Rash—Doxorubicin—hematologic cancer	1.85e-05	6.14e-05	CcSEcCtD
Desmopressin—Dermatitis—Doxorubicin—hematologic cancer	1.85e-05	6.13e-05	CcSEcCtD
Desmopressin—Headache—Doxorubicin—hematologic cancer	1.84e-05	6.1e-05	CcSEcCtD
Desmopressin—Nausea—Doxorubicin—hematologic cancer	1.74e-05	5.78e-05	CcSEcCtD
Desmopressin—PTGS1—Metabolism—NUP214—hematologic cancer	1.7e-05	0.000126	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—EP300—hematologic cancer	1.69e-05	0.000126	CbGpPWpGaD
Desmopressin—PTGS2—Disease—RPS14—hematologic cancer	1.69e-05	0.000126	CbGpPWpGaD
Desmopressin—PTGS2—Disease—DKK1—hematologic cancer	1.68e-05	0.000125	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.68e-05	0.000124	CbGpPWpGaD
Desmopressin—PTGS2—Disease—STAT5B—hematologic cancer	1.67e-05	0.000124	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NUP98—hematologic cancer	1.67e-05	0.000124	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—MTR—hematologic cancer	1.66e-05	0.000123	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ABCG2—hematologic cancer	1.66e-05	0.000123	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—SRC—hematologic cancer	1.65e-05	0.000122	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MAP2K1—hematologic cancer	1.65e-05	0.000122	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—IDH1—hematologic cancer	1.64e-05	0.000121	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.64e-05	0.000121	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PIK3CD—hematologic cancer	1.63e-05	0.000121	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MAP2K1—hematologic cancer	1.63e-05	0.000121	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CST3—hematologic cancer	1.63e-05	0.000121	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ENO2—hematologic cancer	1.63e-05	0.000121	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PIK3CD—hematologic cancer	1.62e-05	0.00012	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.62e-05	0.00012	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	1.62e-05	0.00012	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ADCY7—hematologic cancer	1.62e-05	0.00012	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTO1—hematologic cancer	1.62e-05	0.00012	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—TXN—hematologic cancer	1.62e-05	0.00012	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ABCC3—hematologic cancer	1.62e-05	0.00012	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.61e-05	0.000119	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NUP214—hematologic cancer	1.61e-05	0.000119	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—VEGFA—hematologic cancer	1.6e-05	0.000119	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—KRAS—hematologic cancer	1.6e-05	0.000119	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—KRAS—hematologic cancer	1.59e-05	0.000118	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—STAT3—hematologic cancer	1.59e-05	0.000118	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NRAS—hematologic cancer	1.58e-05	0.000118	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SPHK1—hematologic cancer	1.58e-05	0.000117	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTT1—hematologic cancer	1.58e-05	0.000117	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MTR—hematologic cancer	1.57e-05	0.000117	CbGpPWpGaD
Desmopressin—PTGS2—Disease—XIAP—hematologic cancer	1.57e-05	0.000117	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—FGF2—hematologic cancer	1.56e-05	0.000116	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.56e-05	0.000115	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—FGF2—hematologic cancer	1.55e-05	0.000115	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—SDC1—hematologic cancer	1.54e-05	0.000115	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ENO2—hematologic cancer	1.54e-05	0.000115	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PIK3R1—hematologic cancer	1.54e-05	0.000114	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SMARCA4—hematologic cancer	1.53e-05	0.000114	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PIK3R1—hematologic cancer	1.53e-05	0.000114	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—UGT1A1—hematologic cancer	1.52e-05	0.000113	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—MAPK3—hematologic cancer	1.52e-05	0.000113	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—JAK2—hematologic cancer	1.5e-05	0.000111	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.49e-05	0.000111	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—JAK2—hematologic cancer	1.49e-05	0.00011	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SLC22A1—hematologic cancer	1.48e-05	0.00011	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CRABP1—hematologic cancer	1.48e-05	0.00011	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—MYC—hematologic cancer	1.48e-05	0.000109	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.48e-05	0.000109	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TGFB1—hematologic cancer	1.47e-05	0.000109	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—PIK3CA—hematologic cancer	1.47e-05	0.000109	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MDM2—hematologic cancer	1.46e-05	0.000109	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SDC1—hematologic cancer	1.46e-05	0.000109	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—PIK3CA—hematologic cancer	1.46e-05	0.000108	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.46e-05	0.000108	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MDM2—hematologic cancer	1.45e-05	0.000108	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ALOX5—hematologic cancer	1.44e-05	0.000107	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.44e-05	0.000107	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MTOR—hematologic cancer	1.42e-05	0.000106	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PIK3CB—hematologic cancer	1.42e-05	0.000106	CbGpPWpGaD
Desmopressin—PTGS2—Disease—LCK—hematologic cancer	1.42e-05	0.000105	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MTOR—hematologic cancer	1.41e-05	0.000105	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PIK3CB—hematologic cancer	1.41e-05	0.000105	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NUP98—hematologic cancer	1.4e-05	0.000104	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.39e-05	0.000103	CbGpPWpGaD
Desmopressin—PTGS2—Disease—H3F3A—hematologic cancer	1.39e-05	0.000103	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—KRAS—hematologic cancer	1.36e-05	0.000101	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—HRAS—hematologic cancer	1.36e-05	0.000101	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NCOA3—hematologic cancer	1.36e-05	0.000101	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ADCY7—hematologic cancer	1.36e-05	0.000101	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PRKCZ—hematologic cancer	1.35e-05	0.0001	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—HRAS—hematologic cancer	1.35e-05	0.0001	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NUP214—hematologic cancer	1.35e-05	9.98e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CDKN1B—hematologic cancer	1.34e-05	9.92e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.33e-05	9.88e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CDKN1B—hematologic cancer	1.33e-05	9.85e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CALR—hematologic cancer	1.33e-05	9.84e-05	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—AKT1—hematologic cancer	1.32e-05	9.81e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—MTR—hematologic cancer	1.32e-05	9.78e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ABCG2—hematologic cancer	1.32e-05	9.78e-05	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—AKT1—hematologic cancer	1.31e-05	9.74e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NQO1—hematologic cancer	1.31e-05	9.74e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CD44—hematologic cancer	1.31e-05	9.74e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CASP3—hematologic cancer	1.31e-05	9.72e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—IL2—hematologic cancer	1.31e-05	9.7e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PARP1—hematologic cancer	1.3e-05	9.68e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—IL6—hematologic cancer	1.3e-05	9.66e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CASP3—hematologic cancer	1.3e-05	9.65e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—IL2—hematologic cancer	1.3e-05	9.64e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ENO2—hematologic cancer	1.29e-05	9.59e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—IL6—hematologic cancer	1.29e-05	9.59e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.29e-05	9.54e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FBXW7—hematologic cancer	1.28e-05	9.52e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CCND1—hematologic cancer	1.28e-05	9.46e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—JUN—hematologic cancer	1.27e-05	9.44e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CCND1—hematologic cancer	1.27e-05	9.39e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—JUN—hematologic cancer	1.26e-05	9.37e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HDAC2—hematologic cancer	1.26e-05	9.34e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CXCR4—hematologic cancer	1.26e-05	9.34e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTT1—hematologic cancer	1.25e-05	9.3e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—PIK3CA—hematologic cancer	1.25e-05	9.29e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CD44—hematologic cancer	1.24e-05	9.23e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYCS—hematologic cancer	1.24e-05	9.22e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.24e-05	9.16e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—HSP90AA1—hematologic cancer	1.23e-05	9.16e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CDKN1A—hematologic cancer	1.23e-05	9.15e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PTEN—hematologic cancer	1.23e-05	9.13e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CBL—hematologic cancer	1.23e-05	9.1e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SDC1—hematologic cancer	1.23e-05	9.09e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CDKN1A—hematologic cancer	1.23e-05	9.09e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PTEN—hematologic cancer	1.22e-05	9.07e-05	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.22e-05	9.03e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TP53—hematologic cancer	1.21e-05	8.99e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MAPK8—hematologic cancer	1.2e-05	8.93e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—AKT1—hematologic cancer	1.2e-05	8.91e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MAPK8—hematologic cancer	1.2e-05	8.87e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—AKT1—hematologic cancer	1.19e-05	8.84e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—EP300—hematologic cancer	1.17e-05	8.71e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.17e-05	8.69e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HSP90AA1—hematologic cancer	1.17e-05	8.68e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—EP300—hematologic cancer	1.17e-05	8.65e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—HRAS—hematologic cancer	1.16e-05	8.6e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.16e-05	8.57e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SRC—hematologic cancer	1.14e-05	8.47e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SRC—hematologic cancer	1.13e-05	8.41e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—STAT1—hematologic cancer	1.13e-05	8.37e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—VEGFA—hematologic cancer	1.11e-05	8.25e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.11e-05	8.24e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—IL6—hematologic cancer	1.11e-05	8.23e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.11e-05	8.2e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—VEGFA—hematologic cancer	1.1e-05	8.19e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—STAT3—hematologic cancer	1.1e-05	8.17e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NRAS—hematologic cancer	1.1e-05	8.15e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTP1—hematologic cancer	1.1e-05	8.12e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—STAT3—hematologic cancer	1.09e-05	8.11e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NRAS—hematologic cancer	1.09e-05	8.09e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.06e-05	7.86e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—GRB2—hematologic cancer	1.06e-05	7.83e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PDGFA—hematologic cancer	1.05e-05	7.81e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MAPK3—hematologic cancer	1.05e-05	7.8e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MAPK3—hematologic cancer	1.04e-05	7.75e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CD44—hematologic cancer	1.04e-05	7.73e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NQO1—hematologic cancer	1.04e-05	7.73e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—KITLG—hematologic cancer	1.04e-05	7.7e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ABCB1—hematologic cancer	1.04e-05	7.69e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—AKT1—hematologic cancer	1.02e-05	7.59e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MYC—hematologic cancer	1.02e-05	7.59e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.02e-05	7.57e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TGFB1—hematologic cancer	1.02e-05	7.57e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MYC—hematologic cancer	1.02e-05	7.53e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—STAT5A—hematologic cancer	1.01e-05	7.53e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TGFB1—hematologic cancer	1.01e-05	7.52e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NCOR1—hematologic cancer	1.01e-05	7.46e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTM1—hematologic cancer	1.01e-05	7.46e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CDKN2B—hematologic cancer	1.01e-05	7.46e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYCS—hematologic cancer	9.86e-06	7.32e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—HSP90AA1—hematologic cancer	9.8e-06	7.27e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CD86—hematologic cancer	9.73e-06	7.22e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HES1—hematologic cancer	9.59e-06	7.12e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NCOR1—hematologic cancer	9.54e-06	7.08e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—KRAS—hematologic cancer	9.45e-06	7.01e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGF1—hematologic cancer	9.43e-06	7e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—KRAS—hematologic cancer	9.39e-06	6.96e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FOXO1—hematologic cancer	9.3e-06	6.9e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PDGFRB—hematologic cancer	9.28e-06	6.88e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PDGFRA—hematologic cancer	9.14e-06	6.78e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—JAK1—hematologic cancer	9.1e-06	6.75e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PRKCG—hematologic cancer	9.1e-06	6.75e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—MTHFR—hematologic cancer	8.89e-06	6.6e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.82e-06	6.54e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTP1—hematologic cancer	8.69e-06	6.45e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PIK3CA—hematologic cancer	8.68e-06	6.44e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PIK3CA—hematologic cancer	8.62e-06	6.4e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MTHFR—hematologic cancer	8.43e-06	6.25e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.41e-06	6.24e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HLA-A—hematologic cancer	8.41e-06	6.24e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TERT—hematologic cancer	8.41e-06	6.24e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TP53—hematologic cancer	8.4e-06	6.23e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TP53—hematologic cancer	8.34e-06	6.19e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ABCB1—hematologic cancer	8.23e-06	6.1e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PDGFB—hematologic cancer	8.21e-06	6.09e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—HRAS—hematologic cancer	8.04e-06	5.96e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TSC2—hematologic cancer	8.02e-06	5.95e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NCOR1—hematologic cancer	7.99e-06	5.93e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTM1—hematologic cancer	7.99e-06	5.93e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—HRAS—hematologic cancer	7.98e-06	5.92e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.84e-06	5.81e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGFR3—hematologic cancer	7.72e-06	5.72e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—IL6—hematologic cancer	7.69e-06	5.7e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—IL6—hematologic cancer	7.64e-06	5.66e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CG—hematologic cancer	7.47e-06	5.54e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—BAD—hematologic cancer	7.31e-06	5.43e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NOTCH1—hematologic cancer	7.24e-06	5.37e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CD80—hematologic cancer	7.1e-06	5.26e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—AKT1—hematologic cancer	7.09e-06	5.26e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—KIT—hematologic cancer	7.08e-06	5.25e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—MTHFR—hematologic cancer	7.06e-06	5.24e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—AKT1—hematologic cancer	7.04e-06	5.22e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PTPN11—hematologic cancer	6.96e-06	5.16e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CREBBP—hematologic cancer	6.93e-06	5.14e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CREB1—hematologic cancer	6.74e-06	5e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—BRAF—hematologic cancer	6.66e-06	4.94e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—IL6R—hematologic cancer	6.58e-06	4.88e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CD—hematologic cancer	6.57e-06	4.87e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CREBBP—hematologic cancer	6.57e-06	4.87e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ALB—hematologic cancer	6.49e-06	4.81e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MAP2K1—hematologic cancer	6.27e-06	4.65e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PIK3CD—hematologic cancer	6.23e-06	4.62e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.22e-06	4.62e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3R1—hematologic cancer	6.2e-06	4.6e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGF2—hematologic cancer	5.96e-06	4.42e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CG—hematologic cancer	5.93e-06	4.4e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PIK3R1—hematologic cancer	5.88e-06	4.36e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CB—hematologic cancer	5.73e-06	4.25e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—JAK2—hematologic cancer	5.71e-06	4.24e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MDM2—hematologic cancer	5.58e-06	4.14e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CREBBP—hematologic cancer	5.5e-06	4.08e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PIK3CB—hematologic cancer	5.43e-06	4.03e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MTOR—hematologic cancer	5.43e-06	4.03e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CD4—hematologic cancer	5.42e-06	4.02e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CD—hematologic cancer	5.22e-06	3.87e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ALB—hematologic cancer	5.15e-06	3.82e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CDKN1B—hematologic cancer	5.09e-06	3.78e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PTEN—hematologic cancer	4.95e-06	3.67e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3R1—hematologic cancer	4.92e-06	3.65e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—EP300—hematologic cancer	4.72e-06	3.5e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CDKN1A—hematologic cancer	4.7e-06	3.49e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PTEN—hematologic cancer	4.69e-06	3.48e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CB—hematologic cancer	4.55e-06	3.37e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—EP300—hematologic cancer	4.47e-06	3.32e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SRC—hematologic cancer	4.35e-06	3.23e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—STAT3—hematologic cancer	4.19e-06	3.11e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NRAS—hematologic cancer	4.18e-06	3.1e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MAPK3—hematologic cancer	4.01e-06	2.97e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PTEN—hematologic cancer	3.93e-06	2.91e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MYC—hematologic cancer	3.9e-06	2.89e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TGFB1—hematologic cancer	3.89e-06	2.88e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—EP300—hematologic cancer	3.75e-06	2.78e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—KRAS—hematologic cancer	3.6e-06	2.67e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CA—hematologic cancer	3.49e-06	2.59e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PIK3CA—hematologic cancer	3.31e-06	2.45e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HRAS—hematologic cancer	3.06e-06	2.27e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—IL6—hematologic cancer	2.93e-06	2.17e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—AKT1—hematologic cancer	2.85e-06	2.12e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CA—hematologic cancer	2.77e-06	2.06e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—AKT1—hematologic cancer	2.7e-06	2e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—AKT1—hematologic cancer	2.26e-06	1.68e-05	CbGpPWpGaD
